---
figid: PMC6408732__ijem-17-01-67759-i003
figlink: /pmc/articles/PMC6408732/figure/A67759FIG3/
number: F3
caption: 'Oncogenic BRAF signaling: The mutated BRAF, constitutively activates MEK
  and ERK phosphorylation and pathway activation which at the signals cell proliferation.
  Inhibition of MEK pathway by trematinib (blue arrow T) and blockage of mutated BRAF
  by dabrafenib (green arrow D) suppresses constituve action of the mutated BRAF,
  further inhibiting at two levels the molecule-pathological pathway. Abbreviations:
  MEK, mitogen-activated extracellular signal-regulated kinase; ERK, extracellular
  signal-related kinase.'
pmcid: PMC6408732
papertitle: 'Clinical Trials in Management of Anaplastic Thyroid Carcinoma; Progressions
  and Set Backs: A Systematic Review.'
reftext: Behrouz Salehian, et al. Int J Endocrinol Metab. 2019 Jan;17(1):e67759.
pmc_ranked_result_index: '59388'
pathway_score: 0.9449533
filename: ijem-17-01-67759-i003.jpg
figtitle: 'Oncogenic BRAF signaling: The mutated BRAF, constitutively activates MEK
  and ERK phosphorylation and pathway activation which at the signals cell proliferation'
year: '2019'
organisms:
- Diaporthe sclerotioides
- Bikinia letestui
- Combretum erythrophyllum
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6408732__ijem-17-01-67759-i003.html
  '@type': Dataset
  description: 'Oncogenic BRAF signaling: The mutated BRAF, constitutively activates
    MEK and ERK phosphorylation and pathway activation which at the signals cell proliferation.
    Inhibition of MEK pathway by trematinib (blue arrow T) and blockage of mutated
    BRAF by dabrafenib (green arrow D) suppresses constituve action of the mutated
    BRAF, further inhibiting at two levels the molecule-pathological pathway. Abbreviations:
    MEK, mitogen-activated extracellular signal-regulated kinase; ERK, extracellular
    signal-related kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - HRAS
  - BRAF
  - NRAS
  - MAP2K1
  - MAP2K2
  - MAPK3
  - KRAS
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals: []
diseases: []
figid_alias: PMC6408732__F3
redirect_from: /figures/PMC6408732__F3
figtype: Figure
---
